HEALTH● LOW1h ago · Oct 15, 2026, 10:15 AM
Vanda puts anxiety drug program on hold after Phase III setback
Seeking Alpha Tech · global
Vanda Pharmaceuticals has halted its anxiety drug program following a setback in Phase III trials. This affects the development of new treatments for anxiety and the company's future pipeline.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH1h agoNAFDAC records 213 raids, 474 new cases in eight monthsPremium TimesHEALTHBREAKING1h agoKenya reports second Ebola case, family member of first patientFrance 24 [en]HEALTH2h agoSuspected Fake Surgeon Arrested In Rivers State, Eight Facilities SealedChannels TVHEALTH2h agoMental health at work starts by breaking the taboo, EU agency saysEuroNews [en]